PDCD1 and non-small cell lung carcinoma: With the publication of PACIFIC and several subsequent studies, the PD-1/PDL-1 inhibitors in combination with concurrent/sequential radiotherapy have been recommended as the maintenance or concurrent treatment for the locally advanced NSCLC.